Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TEREX CORP | 62,076 | reported | 02 Feb 2026 | tx 2+64,456 |
| Grace Therapeutics, Inc. | 45,000 | reported | 28 Sept 2022 | tx 2+87,100 |
| Merck & Co., Inc. | 13,609.58 | reported | 24 Feb 2014 | tx 51+457,915.37−89,588 |
| MERCK & CO INC | 0 | reported | 03 Nov 2009 | tx 38+112,048−243,932.37 |
| REV Group, Inc. | 0 | reported | 02 Feb 2026 | tx 15+65,430−65,390 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | GRANT_AWARD | TEREX CORP | 2,380 | 0.00 USD | |
| 02 Feb 2026 | GRANT_AWARD | TEREX CORP | 62,076 | 0.00 USD | |
| 02 Feb 2026 | OTHER | REV Group, Inc. | 63,285 | 0.00 USD | |
| 02 Feb 2026 | OTHER | REV Group, Inc. | 2,105 | 0.00 USD | |
| 03 Dec 2025 | GRANT_AWARD | REV Group, Inc. | 2,105 | 0.00 USD | |
| 05 Dec 2024 | GRANT_AWARD | REV Group, Inc. | 3,611 | 0.00 USD | |
| 08 Dec 2023 | GRANT_AWARD | REV Group, Inc. | 7,084 | 0.00 USD | |
| 08 Dec 2022 | GRANT_AWARD | REV Group, Inc. | 7,960 | 0.00 USD | |
| 28 Sept 2022 | GRANT_AWARD | Grace Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 09 Dec 2021 | GRANT_AWARD | REV Group, Inc. | 5,945 | 0.00 USD | |
| 12 Nov 2021 | GRANT_AWARD | Grace Therapeutics, Inc. | 42,100 | 0.00 USD | deriv |
| 11 Dec 2020 | GRANT_AWARD | REV Group, Inc. | 10,584 | 0.00 USD | |
| 06 Feb 2018 | GRANT_AWARD | REV Group, Inc. | 2,842 | 0.00 USD | |
| 18 Dec 2019 | GRANT_AWARD | REV Group, Inc. | 7,797 | 0.00 USD | |
| 09 Jan 2019 | GRANT_AWARD | REV Group, Inc. | 11,099 | 0.00 USD | |
| 25 Jun 2018 | PURCHASE | REV Group, Inc. | 400 | 16.06 USD | |
| 25 Jun 2018 | PURCHASE | REV Group, Inc. | 4,440 | 16.04 USD | |
| 25 Jun 2018 | PURCHASE | REV Group, Inc. | 200 | 16.05 USD | |
| 26 Jan 2017 | GRANT_AWARD | REV Group, Inc. | 1,363 | 0.00 USD | |
| 24 Feb 2014 | GRANT_AWARD | Merck & Co., Inc. | 2,913 | 56.18 USD | |
| 11 Feb 2014 | EXERCISE | Merck & Co., Inc. | 10,000 | 48.24 USD | |
| 11 Feb 2014 | SALE | Merck & Co., Inc. | 10,000 | 55.70 USD | |
| 11 Feb 2014 | EXERCISE | Merck & Co., Inc. | 10,000 | 0.00 USD | deriv |
| 07 May 2013 | EXERCISE | Merck & Co., Inc. | 4,479 | 0.00 USD | |
| 07 May 2013 | TAX_WITHHOLDING | Merck & Co., Inc. | 1,669 | 44.98 USD |